Cencora Inc.

Healthcare · Medical Distribution

308.80$ -0.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Cencora Inc. (COR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 84,755 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement COR
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	68,922	72,253	68,414	74,241	79,050	81,487	75,454	80,664	83,729	85,932	78,356	84,755	332,771
Cost of Revenue	67,016	70,103	66,157	72,155	76,887	79,223	72,838	78,005	81,125	83,120	75,033	81,148	320,426
Gross Profit	1,907	2,150	2,258	2,087	2,163	2,264	2,616	2,658	2,603	2,812	3,323	3,607	12,345
Selling, General & Administrative	1,394	1,399	1,389	1,383	1,490	1,472	1,600	1,673	1,749	1,795	1,978	2,132	7,654
Total Operating Expenses	1,394	1,399	1,389	1,383	1,490	1,472	1,600	1,673	1,749	1,795	1,978	2,487	8,009
Operating Income	513	751	869	703	673	792	1,016	986	855	1,016	1,345	1,120	4,336
Interest Expense	74	59	77	59	54	61	132	117	109	93	154	141	498
Pre-Tax Income	446	783	467	628	125	620	929	896	-187	709	2,089	996	3,607
Income Tax Expense	97	180	46	141	118	127	211	207	146	143	459	220	967
Net Income	351	602	421	483	3.4	489	718	687	-340	560	1,641	764	2,625
EBITDA	797	1,119	822	966	458	961	1,323	1,269	183	1,041	2,502	1,407	5,134

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings